Key result
In a Belgian primary care survey discussed in this editorial, blood pressure was adequately controlled in only 38% of treated patients and 31% of the overall hypertensive population of older men.
Answers are grounded in this paper and cite their sources.
Highlights the persistent gap between hypertension guidelines and real-world clinical practice, emphasizing the need to address physician inertia and patient non-compliance.
During the last four decades, the management of hypertension has been enriched by the remarkable development of new, effective and well-tolerated antihypertensive drugs. The multiple clinical trials performed with these agents have provided compelling evidence that lowering blood pressure is a very effective way to reduce cardiovascular morbidity and mortality so that, today, hardly any physician would really dispute the need to treat hypertension. Yet, the numerous national or local surveys which have provided a critical appraisal of the quality of hypertension care have consistently demonstrated that the prevalence of patients with unknown hypertension and the percentage of treated hypertensive patients with an uncontrolled blood pressure remain high [1–6], despite all information strategies and the rapidly growing diffusion of national and international guidelines for the management of hypertension [7–10]. Thus, data from the National Health and Nutrition Examination Surveys in the USA show that the awareness of the hypertension population has improved from 50% in the 1970s to approximately 70% in the 1990s [1]. Over the same time, the percentage of treated hypertensive patients with a normal blood pressure has also increased from 10 to 29%, but the most recent survey has found a stabilization of these figures at 27% [1]. In Europe, several studies have reported a percentage of controlled blood pressure ranging between 6 and 30% [2–4,6]. In the present issue of the journal, Fagard et al. present new data obtained in a general practice setting in Belgium [11]. In this survey, the authors examined the prevalence, treatment and control of hypertension in the implementation of the 1999 WHO/ISH guidelines for the management of hypertension in 3761 unselected men (aged at least 55 years) followed by 272 primary care physicians. This population of older hypertensive men is characterized by a high prevalence of hypertension because 74% of them were hypertensive. In accordance with most previous studies, blood pressure was under control (< 140/90 mmHg) in 38% of treated patients and 31% of the entire hypertensive population, and the control of systolic blood pressure was generally poorer than that of diastolic blood pressure. When examining the management of hypertension according to the WHO/ISH cardiovascular risk categories in 1316 patients, the authors found that the percentage of treated patients increased with the level of risk and, within each risk category, patients with higher blood pressure are more likely to be treated than those with lower blood pressure. However, among patients with mild hypertension who were at high or very high risk because of other risk factors, target organ damage or cardiovascular and renal complications, 67 and 33%, respectively were not treated for hypertension. Moreover, the percentage of patients with a well-controlled blood pressure decreased with an increasing level of risk. The physicians’ compliance The data presented by Fagard et al. illustrate once again several important issues regarding the management of hypertension ‘in the real world'. The first issue is the implementation of the official recommendations and the compliance of primary care physicians to these guidelines. In the Belgian study, physicians were invited to meetings at which the guidelines were reviewed. Nevertheless, a great percentage of high and very high cardiovascular risk patients were either not treated or undertreated. This observation is in accordance with several recent reports evaluating treatment practices among primary care physicians [1–6,12]. In one large study, Berlowitz et al. suggested that physicians may not be aggressive enough in their management of hypertension [13]. In a follow-up study, the same investigators tried to identify why physicians were reluctant to intensify treatment in patients with uncontrolled hypertension [14]. In this survey, all physicians claimed that they were either very familiar or somewhat familiar with the JNC VI guidelines for treating hypertension. The most frequent reason why treatment was not adapted is that physicians were satisfied with the achieved blood pressures although they were not on target [14]. In another survey, conducted among 1200 primary care physicians, Hyman et al. assessed the treatment practices using a questionnaire and found that 25% of physicians would not intensify therapy for a persistent diastolic blood pressure of 94 mmHg in a patient without complication [15]. In the same clinical situation, one third of the physicians would not intensify therapy for a systolic BP of 158 mmHg. These data clearly indicate that primary care physicians have different BP thresholds than those recommended by official guidelines. They also reflect that there is still some uncertainty among general practitioners about the importance of systolic BP in elderly patients. This may explain why a large proportion of patients with uncontrolled BP have an isolated systolic hypertension. Why is there such a discrepancy between recommendations and clinical practice? Among the possible answers, the easiest one is that physicians are not really aware of the content of the guideline. A large German survey (contacting 11 547 physicians) recently reported that an awareness of adequate guidelines was present in 18.8% of general practitioners, 25.6% of internists and 37% of cardiologists [15]. In a smaller American study, 41% of 316 physicians had either not heard or were not familiar with the content of the national guidelines [16]. This suggests that information strategies should be improved. Another possible reason for the discrepancy is that physicians do not always feel that the patients who were included in the clinical trials (which are the usual base of the ‘clinical evidence') are representative of their own patient population. Indeed, therapeutic trials often exclude a large number of patients because of associated clinical problems. A classical example is the Systolic Hypertension in the Elderly Program, which enrolled 4736 patients out of 447 921 screened persons (i.e. approximately 1%) [17]. Primary care physicians have to manage the 447 921 patients. Published guidelines and recommendations are generally written by expert panels. It may be wise to include more primary care physicians who are aware of the many constraints of daily ambulatory care medicine in such panels. Patient compliance The results of the Hypertension Optimal Treatment (HOT) trial have demonstrated that between two-thirds and three-quarters of patients require several antihypertensive drugs to reach the pre-defined therapeutic goals (i.e. a diastolic blood pressure below 90, 95 or 80 mmHg) [18]. If one considers that isolated systolic hypertension is generally more difficult to control than diastolic blood pressure, there is little doubt that most elderly hypertensive patients will also require multiple drug therapy. Interestingly, in the study by Fagard et al., 50% of treated patients received monotherapy, a drug regimen which is not expected to control blood pressure adequately in more than 40% of patients [11]. The reason why primary care physicians do not use more antihypertensive drugs is not clear. It is possible that physicians are reluctant to add new drugs because it would enhance the complexity of the regimen and thereby promote non-adherence; hence, they become satisfied with sub-optimal controls of blood pressure. This attitude is particularly common when dealing with elderly patients who are treated for several concomitant diseases. Patient compliance to drug therapy has been recognized as one of the major reasons why antihypertensive therapy fails [7,19]. In a US survey of 3740 physicians, failure to take medications as instructed was among the most frequently cited impediments to blood pressure control [20]. On their side, patients tend to claim that they always take their medication correctly and attribute the failure to reach the therapeutic goal to the poor efficacy of antihypertensive drugs. Although non-compliance is recognized as a major clinical problem in many guidelines or recommendations for clinical practice, there exists an enormous gap between the increasing emphasis on poor compliance as an important cause of less than optimal blood pressure control and the complete lack of action taken to objectively measure and enhance compliance in everyday practice. The frequently encountered ‘resistance’ of a given hypertensive patient to an association of two or more antihypertensive agents always raises the unanswerable question of inadequate pharmacological regimen versus inadequate compliance [21]. Without any objective measurement of drug compliance, we almost always opt for an inadequate pharmacological regimen, and consequently for enhancing doses or prescribing new drug combinations. We are indeed so accustomed to this routine that we are no longer aware of how poor the rational basis for such a decision is. The recent development of electronic monitors of compliance may offer a new opportunity to improve the detection and quantitative assessment of non-compliance [21–24]. Today, additional information still needs to be gathered to define more precisely how these devices should be used in clinical practice and whether long-term benefits on blood pressure control can be expected from more frequent use by primary care physicians. Clinicians and health care providers are increasingly being asked to be accountable for the care they provide. Now that many reports, such as the one by Fagard et al., have clearly documented the importance of the problem, all efforts should be made to close the therapeutic gap. Therefore, studies should be conducted to reveal the reasons behind the physicians’ non-adherence to clinical practice guidelines, and new strategies to improve their implementation should be tested. In parallel, new strategies must be developed to enhance patient adherence, starting with a better detection of poor compliance. With such approaches, there would be an improvement of general hypertension management and the consequent application of clinical interventions that have been demonstrated to be effective.
No takes yet. Share an insight, caveat, or question.
Michel Burnier (2002) conducted an editorial in Hypertension (n=3,761). Guideline-directed management of hypertension was evaluated on Blood pressure control (< 140/90 mmHg). In a Belgian primary care survey discussed in this editorial, blood pressure was adequately controlled in only 38% of treated patients and 31% of the overall hypertensive population of older men.
Synapse has enriched 10 related papers. Consider them for comparative context: